Partner Headlines - INFI

  1. Benzinga's Top Initiations

    Benzinga
  2. It's A Big Weekend For Biotech

    Benzinga
  3. JPM Securities Picks Through Biotech News For Winners

    Benzinga
  4. UPDATE: Infinity Pharmaceuticals Posts Q4 Loss

    Benzinga
  5. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  6. Morning Market Losers

    Benzinga
  7. Pharmaceuticals, Therapeutics And A Retailer On The Move Thursday ...

    Benzinga
  8. Benzinga's Top #PreMarket Losers

    Benzinga
  9. Infinity Announces Clinical And Preclincal Data For Duvelisib ...

    Benzinga
  10. Infinity Reports Topline Data From Phase 2a Exploratory Study ...

    Benzinga
  11. 3 Partnerships Pushing The Pharmaceutical Sector Forward

    Benzinga
  12. Pharmacyclics Price Target Cut On Higher Spending

    IBD
  13. Benzinga's Top Upgrades

    Benzinga
  14. JMP Securities Upgrades Infinity Pharmaceuticals To Market Outperform

    Benzinga
  15. Infinity, AbbVie team on drug

    IBD
  16. S&P 500 Struggles To Hold 2,000 As Commodities Rebound

    Benzinga
  17. Midday Gainers From Wednesday, September 3

    Benzinga
  18. Infinity Pharma Joins AbbVie On Blood Cancer Drug

    IBD
  19. NASDAQ Tumbles 0.5%; Infinity Pharmaceuticals Jumps On Deal With ...

    Benzinga
  20. Markets Gain; Toll Brothers Profit Beats Estimates

    Benzinga
  21. Benzinga's Volume Movers

    Benzinga
  22. Morning Market Movers

    Benzinga
  23. Stock Futures Up And Climbing; Baidu Heads China Stock Rally

    IBD
  24. Benzinga's Top #PreMarket Gainers

    Benzinga
  25. What You Need to Know About the Roche-InterMune Deal

    Benzinga
  26. Markets Open Higher; Burger King In Talks To Buy Tim Hortons

    Benzinga
  27. InterMune's Roche Deal Sends Peer Group Up

    Benzinga
  28. 3 Small-Cap Biotechs That Institutions Are Loving

    Benzinga
  29. UPDATE: Morgan Stanley Initiates Coverage On Infinity Pharmaceuticals ...

    Benzinga
  30. The Top Five Drug Launches Of 2013

    IBD
  31. UPDATE: Credit Suisse Downgrades Infinity Pharmaceuticals on ...

    Benzinga
  32. Benzinga's Top Downgrades

    Benzinga
  33. Celgene's stock hits new high

    IBD
  34. Mid-Day Market Update: Sysco Shares Rise Following Merger with ...

    Benzinga
  35. Celgene, Infinity Rise On Blood Cancer Drug Data

    IBD
  36. Benzinga's Volume Movers

    Benzinga
  37. Infinity Reports Encouraging Phase 1 IPI-145 Data at ASH

    Benzinga
  38. Infinity Announces Updated Phase 1 Data of IPI-145 in iNLH at ...

    Benzinga
  39. Infinity Announces Updated Phase 1 Data of IPI-145 in iNLH at ...

    Benzinga
  40. UPDATE: William Blair Initiates Coverage on Infinity Pharmaceuticals ...

    Benzinga
  41. Benzinga's Top Initiations

    Benzinga
  42. The Best Small Cap Performers of 2012

    Benzinga
  43. Stocks Hitting 52-Week Highs

    Benzinga
  44. Infinity Pharma Amends Millennium Deal for PI3K-Delta, Gamma

    Benzinga
  45. Infinity Announces Amended PI3K-Delta,Gamma Agreement with Millennium

    Benzinga
  46. Infinity Announces Closing of Public Offering and Exercise of ...

    Benzinga
  47. Stocks Hitting 52-Week Highs

    Benzinga
  48. Infinity Pharma Prices 5.696M Shares at $26.33

    Benzinga
  49. Mid-Afternoon Market Update: Markets Continue to Rise, Diamond ...

    Benzinga
  50. Infinity Pharma Shares Rebound Over $22 Following Phase I Data ...

    Benzinga
  51. UPDATE: Jefferies Downgrades Infinity Pharmaceuticals to Hold ...

    Benzinga
  52. INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q)

    GuruFocus
  53. Stocks Hitting 52-Week Highs

    Benzinga
  54. UPDATE: Stifel Nicolaus Initiates Infinity Pharmaceuticals at ...

    Benzinga
  55. INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q)

    GuruFocus
  56. Health Care Sector Wrap

    FoxBusiness
  57. Synacor, American Capital Mortgage Investment Crp, Other Stocks ...

    FoxBusiness
  58. Infinity Pharmaceuticals Shuts Down Cancer Trials

    Benzinga
  59. Morning Market Losers

    Benzinga
  60. Benzinga's Top Pre-Market Losers

    Benzinga
  61. A Peek Into The Market Before The Trading Starts

    Benzinga
  62. UPDATE: Piper Jaffray Lowers PT on Infinity Pharmaceuticals to ...

    Benzinga
  63. Infinity Plummets on Disappointing Phase 2 Study

    Benzinga
  64. Piper Jaffray Lowers PT on Infinity Pharmaceuticals to $8

    Benzinga
  65. Infinity Reports Update from Phase 2 Study of Saridegib Plus ...

    Benzinga
  66. Infinity Reports New Data from Phase 1b Trial of Saridegib in ...

    Benzinga
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!